CTECH-104A NAVIGATORTAMPERING DETECTED
19:4024%
Routine background scan initiated. No threats found.
Network encrypted [4096-bit]. Idle state.

@encrypted_user_24: _
This is content directly ported from the old campaign, and thus has not yet been reviewed - general vibes, themes, and broad details are probably still accurate, but check any fine details.

Nera-Vue Group

  • Flagship Product: Synthneuron and Neural Interface Technology
  • Primary Industries: Pharmaceuticals, Augmentation, Medical Research
  • Corporate Culture: Responsible, over-cautious, moralistic. Wary of outsiders.
  • Company Leadership: Worker-Shares Owned Company.

Nera-Vue Laboratories claim to be a 'De-Centralised, Pro-Environmental Medical Science Initiative' and have heavy investment in numerous associated fields, including agricultural science and cellular magical research. With facilities dotted in numerous areas across Dranend, they are responsible for both Neural Interfacing Technology - and study into their own medication, Neracytrin. While their public relations presents an open-ended front, and many research papers and patents are published for public use regularly - their facilities are often regarded as the most secured to be found.

Nera-Vue make the majority of their funding from the patents of their Direct Neural Interfacing technology, and from prolonged sales of their Neracytrin medication, used to negate the negative side effects associated with neuro-tech bonding procedures. The corporation has come under regular fire for the conflict of interests provided, and many have suggested that the medical need is an intentional biproduct of their design.